Escape mechanisms after antiangiogenic treatment, or why are the tumors growing again?

Area of Science:

• Oncology
• Vascular Biology
• Cancer Therapy

Background:

• Angiogenesis inhibitors are effective in preclinical cancer models but show limited efficacy in clinical trials, particularly as monotherapy.
• Tumor recovery and therapy resistance remain significant challenges in cancer patient management.
• The precise mechanisms driving tumor recovery following treatment are not fully understood.

Purpose of the Study:

• To review the adaptive changes in tumor vasculature during and after anti-cancer therapy.
• To elucidate the role of intussusceptive angiogenesis as a compensatory mechanism in tumor vasculature.
• To identify potential molecular targets for improving anti-angiogenic therapies.

Main Methods:

• Literature review of preclinical and clinical studies on angiogenesis inhibitors and radiation therapy.
• Analysis of adaptive vascular responses in tumor models.
• Discussion of mechanisms underlying therapy resistance and tumor recovery.

Main Results:

• Tumor vasculature undergoes compensatory changes in response to angiogenesis inhibitors and radiation.
• A transient switch from sprouting to intussusceptive angiogenesis may be an adaptive response.
• This angioadaptive mechanism helps maintain functional properties of tumor vasculature during therapy.

Conclusions:

• Understanding the switch to intussusceptive angiogenesis is crucial for overcoming therapeutic resistance.
• Targeting this adaptive angio-mechanism could enhance the efficacy of current anti-angiogenic treatments.
• Further research is needed to identify specific molecular targets for improved cancer therapy.